Home | Site Map | Contact Us |  Tell a Colleague | Print Page  
CellCept (mycophenolate mofetil) Roche
About Roche Transplantation Research Resources for Professionals Prescribing Information Community Support Industry Events/News
Sign Up
Login Here
E-mail
Password
Forgot Password

Important Safety and Prescribing Information

CellCept Zenapax Valcyte Learn More about Cellcept

Indications 

CellCept is indicated for the prevention of organ rejection in patients receiving

  • Renal transplants (approved in 1995)
  • Cardiac transplants (approved in 1998)
  • Hepatic transplants (approved in 2000)

CellCept should be used in combination with cyclosporine and corticosteroids.

  Safety Information

 

 

 

 

 

 

 

 

 
Privacy Statement  |  Legal Statement  |  Intended for U.S. Physician Audiences Only Copyright © 2006-2009 - Roche Laboratories Inc. All rights reserved.